29.03.2016 • NewsElaine BurridgeEvonikcapacity expansion

Evonik Begins Silicones Project in China

Evonik has broken ground on a new plant to produce organically modified specialty silicones in China. The project is part of a global silicones expansion program that the German company announced in March 2015.

The facility is located on the Multi-User-Site (MUSC) in the Shanghai Chemical Industry Park and completion is planned for the middle of 2017. Capacity details were not disclosed but investment costs were put in the high double-digit million euro range.

Klaus Engel, chairman of Evonik’s executive board, said the company wanted to expand specialty silicones capacity in Asia to serve rising demand with local production.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.